J Liver Cancer.  2015 Sep;15(2):84-87. 10.0000/jlc.2015.15.2.84.

An A to Z of Lipiodol Beyond the Clinical Practice in the Management of Hepatocellular Carcinoma

Affiliations
  • 1Division of Gastroenterology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea. mseileen80@naver.com

Abstract

Lipiodol based conventional transarterial chemoembolization (TACE) is a standard of care for unresectable, non-invasive, and multinodular Hepatocellular carcinoma (HCC)s. The procedure relies on the intra-arterial administration of lipiodol/cytotoxic agent emulsion followed by the infusion of embolic material. Lipiodol, with its oily nature and radiopacifying properties, is in the center of the TACE procedure. Unstability and unpredictable therapeutic effect of hydrophilic cytotoxic drugs emulsified in the lipiodol and technical problems lie beyond the control of clinicians. Thus, interest in the properties and respective roles for lipiodol in the management of HCC is essential for the clinicians.

Keyword

Lipiodol; Hepatocellular carcinoma; Transarterial chemoembolization

MeSH Terms

Carcinoma, Hepatocellular*
Ethiodized Oil*
Standard of Care
Ethiodized Oil
Full Text Links
  • JLC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr